Financhill
Back

Vertex Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53

VRTX
Vertex Pharmaceuticals, Inc.

Last Price:
$459.20
Seasonality Move:
7.07%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Vertex Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 452.76 Buy
20-day SMA: 445 Buy
50-day SMA: 431.21 Buy
200-day SMA: 440.98 Buy
8-day EMA: 288.28 Buy
20-day EMA: 149.73 Buy
50-day EMA: 67.07 Buy
200-day EMA: 17.78 Buy

Vertex Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 101.15 Buy
Relative Strength Index (14 RSI): 62.54 Buy
Chaikin Money Flow: 773103 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (428.72 - 454.46) Buy
Bollinger Bands (100): (388.9 - 437.64) Buy

Vertex Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Vertex Pharmaceuticals, Inc. Stock

Is Vertex Pharmaceuticals, Inc. Stock a Buy?

VRTX Technical Analysis vs Fundamental Analysis

Buy
53
Vertex Pharmaceuticals, Inc. (VRTX) is a Buy

Is Vertex Pharmaceuticals, Inc. a Buy or a Sell?

Vertex Pharmaceuticals, Inc. Stock Info

Market Cap:
116.8B
Price in USD:
460.31
Share Volume:
919.6K

Vertex Pharmaceuticals, Inc. 52-Week Range

52-Week High:
519.68
52-Week Low:
362.50
Buy
53
Vertex Pharmaceuticals, Inc. (VRTX) is a Buy

Vertex Pharmaceuticals, Inc. Share Price Forecast

Is Vertex Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Vertex Pharmaceuticals, Inc.

Is Vertex Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.96 per share, and an increase next year of $1.79 per share.

Technical Analysis of Vertex Pharmaceuticals, Inc.

Should I short Vertex Pharmaceuticals, Inc. stock?

* Vertex Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.